Drug usage evaluation of dapsone

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 4, 2009, Pages 456-460

  Kannan, G ^a   Vasantha, J ^a   Rani, N ^a   Thennarasu, P ^a   Kousalya, K ^a   Anuradha, P ^a   Umamaheswara Reddy, C ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Adverse effects; Dapsone; Drug usage evaluation; Patient education

Indexed keywords

CLOFAZIMINE; DAPSONE; PREDNISOLONE; RIFAMPICIN;

ABDOMINAL PAIN; ACNE; ADULT; ANOREXIA; ARTICLE; BULLOUS PEMPHIGOID; DELAYED HYPERSENSITIVITY; DERMATITIS HERPETIFORMIS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ERYTHEMATOUS PEMPHIGUS; FEMALE; FEVER; HAILEY HAILEY DISEASE; HEADACHE; HUMAN; INSOMNIA; IRRITANT DERMATITIS; LEPROSY; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT INFORMATION; PEMPHIGUS VULGARIS; PERIPHERAL NEUROPATHY; PRESCRIPTION; PSORIASIS; SINGLE DRUG DOSE; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TINNITUS; VERTIGO; WORLD HEALTH ORGANIZATION;

EID: 71049163853     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.57301     Document Type: Article

References (18)

1. Wozel G. The story of sulphones in tropical medicine and dermatology. Int J Dermatol 1989;28:17-21.
2. Gennaro AR ed. In: Remington: The Science and Practice of Pharmacy, 20th ed. Vol.2. Philadelphia: Lippincott Williams & Wilkins, 2000. p. 1543.
3. Prendville J, Logan R, Russel-Jones R. A Comparison of dapsone with 13-cis retinoic acid in the treatment of nodular cystic acne. Br J Dermatol 1988;13:67-71.
4. Ghate J, Jorizzo J. Behcet's disease and complex aphthosis. J Am Acad Dermatol 1999;40:1-18.
5. Jeffes E, Ahmed A. Adjuvant therapy of bullous pemphigoid with dapsone. Clin Exp Dermatol 1989;14:132-136
6. Leoung G, Milles J, Hopewell P. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986;105:45-48
7. Leonard J, Fry L. Treatment and management of dermatitis herpetiformis. Clin Dermatol 1991:9:403-408
8. Barranco V, Minor D, Solomon H. Treatment of relapsing polychondritis with dapsone. Arch Dermatol 1976;112:1286-1288
9. Hall R, Lawley T, Smith H, Katz S. Bullous eruption of systemic lupus erythematosus: Dramatic response to dapsone therapy. Ann Intern Med 1982;97:165-170
10. Jablonska S, Chorzelski T, Beutner E, Chorzelska J. Herpetiform pemphigus: A variable pattern of phemphgus. Int J Dermatol 1975;14:353-359
11. Brunsting L, Goeckerman W, O'Leary P. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930;22:655-680
12. Benavides M, Moncada X. The treatment of cutaneous loxoscelism with dapsone. Rev Med Chil 1990;118:1247-1250
13. Forston JS, Zone J, Hammond ME, Groggel GC. Hypocomplimentemic Urticarial Vasculitis syndrome response to dapsone. J Am Assn Dermatol 1986;15:1137-1142
14. Gerald K Mc Evoy, Jane Miller, Kathy Litvak (Editors). AHFS Drug Information. USA: American Society of Health System Pharmacists; 2004. p.587-589
15. Study of cancer incidence in relation to dapsone use - Executive summary. Australian Government, Department of Veteran's affairs. Available from: http://www.dva.gov.av/media/publicat/dapsone.htm.
16. http://www.Dapsone-British Association of Dermatologists.htm.
17. Marks JG Jr, Miller JJ, editors. In: Lookingbill and Mark's Principles of Dermatology, 4th ed. Philadelphia: Elseviers; 2009. p.190-197
18. Habif TP, Campbell JL Jr, Chapman SM, Dinulos JG, Zug KA, editors. In: Skin Diseases-Diagnosis and Treatment, 2nd ed. Amsterdam: Elseviers; 2005.